# Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia

> **NCT01576640** · PHASE4 · TERMINATED · sponsor: **Massachusetts General Hospital** · enrollment: 17 (actual)

## Conditions studied

- Nicotine Dependence
- Schizophrenia

## Interventions

- **DRUG:** NRT
- **DRUG:** Bupropion SR 150mg bid
- **OTHER:** Relapse Prevention-Oriented Cognitive Behavioral Therapy

## Key facts

- **NCT ID:** NCT01576640
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-12
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2015-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01576640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01576640, "Extended Duration Nicotine Replacement Therapy and Bupropion in Smokers With Schizophrenia". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01576640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*